Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2010
08/17/2010US7776341 Using superoxide dismutase and thyrodoxin profiles as diagnostic tools for characterizing mycobacterial infection
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7776338 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans
08/17/2010US7776337 novel lactic acid-producing strains; Lactobacillus acidophilus; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry
08/17/2010US7776336 Compositions comprising Yersinia pestis antigens
08/17/2010US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/17/2010US7776334 administering hematopoietic cells to increase blood platelet; for patient receiving cancer chemotherapy or radiation therapy, or immunosuppressants; treating blood disorders anemia, myeloma, non-Hodgkin's lymphoma, Hodgkins lymphoma and leukaemia
08/17/2010US7776333 Obtained from fraction(s) precipitated by ammonium sulfate precipitation using an aqueous extract from Pleurotus cornucopiae; protein has an antifungal activity against rice blast; genetic engineering
08/17/2010US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk
08/17/2010US7776331 administering an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23
08/17/2010US7776330 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule
08/17/2010US7776328 Antibodies that bind to EphA2 and methods of use thereof
08/17/2010US7776327 Formulations that interact with and alter expression of epithelial cell tyrosine kinase
08/17/2010US7776324 Cancer vaccine
08/17/2010US7776323 Streptococcus suis vaccines and diagnostic tests
08/17/2010US7776311 D-amino acid peptides
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2352563C Method to produce inactivated w/o emulsion adjuvanted vaccines
08/17/2010CA2302522C Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2203679C Oral immunization with transgenic plants
08/12/2010WO2010091324A1 Dual inhibition of immunophilin/cyclophilin and emmprin immunoglobulin receptor superfamily members
08/12/2010WO2010091189A1 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
08/12/2010WO2010090873A2 Polypeptides and their use as adjuvants
08/12/2010WO2010090758A2 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
08/12/2010WO2010090707A2 A nef deleted human immunodeficiency virus for the restoration of t-lymphocyte signalling and activation for the treatment and prevention of human immunodeficiency virus infection
08/12/2010WO2010090532A1 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
08/12/2010WO2010090523A1 Truncated cystine-knot proteins
08/12/2010WO2010090272A1 Remedy for chronic inflammation and antibody to be used therein
08/12/2010WO2010090040A1 Monoclonal antibodies that recognize cholangiocarcinoma-specific sugar chain epitopes
08/12/2010WO2010089940A1 Mucosal vaccine
08/12/2010WO2010089782A1 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
08/12/2010WO2010089671A2 Contiguous overlapping peptides for treatment of birch pollen allergy
08/12/2010WO2010089554A1 Peptides for vaccine
08/12/2010WO2010089411A2 Pd-1 antibodies and pd-l1 antibodies and uses thereof
08/12/2010WO2010089402A1 Splitting gp41
08/12/2010WO2010089400A1 Novel gp41 antigens
08/12/2010WO2010088857A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof
08/12/2010WO2010088803A1 New porcine reproductive and respiratory syndrome virus receptor, and blockers thereof
08/12/2010WO2010088739A1 Sam-6 variants, target and methods of use
08/12/2010WO2010068968A8 Methods and compositions for use of a coccidiosis vaccine
08/12/2010WO2010066418A8 Use of flt3 ligand for strengthening immune responses in rna immunization
08/12/2010WO2010065140A3 Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza
08/12/2010WO2010034974A3 Tuberculosis vaccines targeted to cd40
08/12/2010WO2010021516A9 Novel use of lipocalin 2 for treating brain damage
08/12/2010WO2010019954A9 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
08/12/2010WO2009108360A3 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
08/12/2010WO2009036338A3 Methods for addressing ocular diseases through interference with the wnt signaling pathway
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204304 NOGO Receptor Binding Protein
08/12/2010US20100204147 Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
08/12/2010US20100204126 Therapy for melanin related afflictions
08/12/2010US20100204051 Hereditary Hemochromatosis Gene
08/12/2010US20100203597 Recombinant reverse transcriptases
08/12/2010US20100203568 Assay Method For Peptide Specific T-Cells
08/12/2010US20100203168 Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate
08/12/2010US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders
08/12/2010US20100203143 Systems and methods for nanomagnetic actuation of molecular cell signaling
08/12/2010US20100203142 Amphiphilic compound assisted nanoparticles for targeted delivery
08/12/2010US20100203139 Nanoemulsion therapeutic compositions and methods of using the same
08/12/2010US20100203137 Formulation of meningitis vaccines
08/12/2010US20100203136 METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION
08/12/2010US20100203122 Delivery System for Remote Treatment of an Animal
08/12/2010US20100203109 Methods and Compositions for Treating Melanoma
08/12/2010US20100203103 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
08/12/2010US20100203086 Attack of tumor cells with missing, low or aberrant mhc expression by combining non mhc-restricted t-cells/nk-cells and mhc-restricted cells
08/12/2010US20100203085 Toxoplasma Gondii Vaccines and Uses Thereof
08/12/2010US20100203084 Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
08/12/2010US20100203083 Mutated structural protein of a parvovirus
08/12/2010US20100203082 Virus-modified bacteria ghosts
08/12/2010US20100203081 Viral inhibitory nucleotide sequences and vaccines
08/12/2010US20100203080 Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof
08/12/2010US20100203076 Complexes of rna and cationic peptides for transfection and for immunostimulation
08/12/2010US20100203075 Chlamydia antigens
08/12/2010US20100203074 Compositions and methods for treating intracellular diseases
08/12/2010US20100203073 Hsv-1 epitopes and methods for using same
08/12/2010US20100203072 Circovirus sequences associated with piglet weight loss disease (pwd)
08/12/2010US20100203071 Chimeric antigens
08/12/2010US20100203070 Contiguous Overlapping Peptides for Treatment of Birch Pollen Allergy
08/12/2010US20100203069 Antisense Respiratory Syncytial Virus Vaccine and Therapy
08/12/2010US20100203068 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3
08/12/2010US20100203067 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
08/12/2010US20100203066 Polymeric linkers containing pyridyl disulfide moieties
08/12/2010US20100203065 Human liver regeneration associated protein and the use thereof
08/12/2010US20100203064 Methods and compositions for modulating wound repair
08/12/2010US20100203063 Pestivirus species
08/12/2010US20100203062 Methods and Compositions for Treatment of Neovascularization
08/12/2010US20100203061 Prevention and treatment of retinal ischemia and edema
08/12/2010US20100203060 Inhibitors for growth hormone and related hormones, and methods of use thereof
08/12/2010US20100203059 Method of treating a pathological syndrome and a pharmaceutical agent
08/12/2010US20100203058 Diagnostics and therapeutics based on circulating progenitor cells
08/12/2010US20100203057 Novel compounds
08/12/2010US20100203056 Anti-pd-l1 antibodies and their use to enhance t-cell function
08/12/2010US20100203055 Hair regrowth promoter
08/12/2010US20100203054 Wnt Proteins and Detection and Treatment of Cancer
08/12/2010US20100203053 Method and composition for treating immune complex associated disorders
08/12/2010US20100203052 Binding domain-immunoglobulin fusion proteins
08/12/2010US20100203051 Diagnostic markers for ankylosing spondylitis and uses thereof
1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 1823